Cargando…
p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
Expression of both P-glycoprotein (P-gp) and mutant p53 have recently been reported to be associated with poor prognosis of breast cancer. The expression of P-gp is associated in vitro and in vivo with cross-resistance to several anti-cancer drugs. p53 plays a regulatory role in apoptosis, and mutan...
Autores principales: | Linn, S. C., Honkoop, A. H., Hoekman, K., van der Valk, P., Pinedo, H. M., Giaccone, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074603/ https://www.ncbi.nlm.nih.gov/pubmed/8679460 |
Ejemplares similares
-
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.
por: Honkoop, A. H., et al.
Publicado: (1998) -
Cortisol is transported by the multidrug resistance gene product P-glycoprotein.
por: van Kalken, C. K., et al.
Publicado: (1993) -
p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010) -
Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
por: Iwaya, Keiichi, et al.
Publicado: (1991) -
CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
por: Jansen, W. J., et al.
Publicado: (1998)